These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1899875)

  • 1. Response to chemotherapy in experimental visceral leishmaniasis: T cell-dependent but interferon-gamma- and interleukin-2-independent.
    Murray HW; Granger AM; Mohanty SK
    J Infect Dis; 1991 Mar; 163(3):622-4. PubMed ID: 1899875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.
    Murray HW; Montelibano C; Peterson R; Sypek JP
    J Infect Dis; 2000 Nov; 182(5):1497-502. PubMed ID: 11023473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis.
    Murray HW; Delph-Etienne S
    Infect Immun; 2000 Jan; 68(1):288-93. PubMed ID: 10603400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
    Murray HW
    Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.
    Murray HW; Oca MJ; Granger AM; Schreiber RD
    J Clin Invest; 1989 Apr; 83(4):1253-7. PubMed ID: 2539396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine.
    Murray HW; Hariprashad J; Fichtl RE
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1504-5. PubMed ID: 8363382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection.
    Murray HW; Hariprashad J; McDermott DF; Stoeckle MY
    Infect Immun; 1996 Jan; 64(1):161-6. PubMed ID: 8557335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
    Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
    J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role and effect of IL-2 in experimental visceral leishmaniasis.
    Murray HW; Miralles GD; Stoeckle MY; McDermott DF
    J Immunol; 1993 Jul; 151(2):929-38. PubMed ID: 8335921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio.
    Haldar AK; Banerjee S; Naskar K; Kalita D; Islam NS; Roy S
    Exp Parasitol; 2009 Jun; 122(2):145-54. PubMed ID: 19422069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.
    Murray HW; Luster AD; Zheng H; Ma X
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice.
    Murray HW; Hariprashad J; Aguero B; Arakawa T; Yeganegi H
    J Infect Dis; 1995 May; 171(5):1309-16. PubMed ID: 7751708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.
    Murray HW; Flanders KC; Donaldson DD; Sypek JP; Gotwals PJ; Liu J; Ma X
    Infect Immun; 2005 Jul; 73(7):3903-11. PubMed ID: 15972476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation.
    Murray HW
    Infect Immun; 2000 Nov; 68(11):6294-9. PubMed ID: 11035738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
    Murray HW; Moreira AL; Lu CM; DeVecchio JL; Matsuhashi M; Ma X; Heinzel FP
    J Infect Dis; 2003 Aug; 188(3):458-64. PubMed ID: 12870129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
    Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
    Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
    Carvalho EM; Badaró R; Reed SG; Jones TC; Johnson WD
    J Clin Invest; 1985 Dec; 76(6):2066-9. PubMed ID: 3935667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
    Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
    J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis.
    Sundar S; Singh VP; Sharma S; Makharia MK; Murray HW
    J Infect Dis; 1997 Oct; 176(4):1117-9. PubMed ID: 9333181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.